Acorda Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Acorda Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $8.44M, a 11.4% increase year-over-year.
  • Acorda Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $32.4M, a 7.25% increase year-over-year.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2023 was $31.5M, a 4.41% increase from 2022.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2022 was $30.2M, a 0.55% increase from 2021.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2021 was $30M, a 1.76% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $32.4M $8.44M +$865K +11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $31.5M $8.21M +$506K +6.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $31M $7.98M +$519K +6.95% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $30.5M $7.77M +$299K +4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $30.2M $7.57M +$9K +0.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $30.2M $7.7M +$361K +4.92% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $29.8M $7.47M +$298K +4.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $29.5M $7.47M -$231K -3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $29.8M $7.56M -$263K -3.36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $30M $7.34M -$426K -5.49% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $30.5M $7.17M -$593K -7.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $31.1M $7.71M +$221K +2.95% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $30.8M $7.83M +$259K +3.42% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $30.6M $7.76M +$2.19M +39.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $28.4M $7.76M +$3.26M +72.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $25.1M $7.48M +$2.11M +39.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $23M $7.57M +$1.14M +17.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $21.9M $5.57M +$299K +5.67% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $21.6M $4.5M -$915K -16.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $22.5M $5.38M -$36K -0.67% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $22.5M $6.42M +$927K +16.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $21.6M $5.27M +$390K +7.99% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $21.2M $5.42M +$1.24M +29.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $20M $5.41M -$46K -0.84% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $20M $5.5M +$1.35M +32.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $18.7M $4.88M +$514K +11.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $18.2M $4.18M -$224K -5.09% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $18.4M $5.46M +$1.43M +35.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $16.9M $4.14M +$420K +11.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $16.5M $4.37M +$993K +29.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $15.5M $4.4M +$367K +9.09% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $15.2M $4.03M +$23K +0.57% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $15.1M $3.72M -$328K -8.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $15.5M $3.37M -$799K -19.1% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 $16.3M $4.04M -$560K -12.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $16.8M $4.01M +$3.58M +841% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $13.2M $4.05M +$3.96M +4303% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $9.29M $4.17M +$3.89M +1359% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $5.4M $4.6M +$4.05M +745% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.35M $426K -$323K -43.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.67M $92K -$499K -84.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $2.17M $286K -$99K -25.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $2.27M $544K +$171K +45.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $2.1M $749K +$393K +110% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.71M $591K -$175K -22.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $1.88M $385K +$174K +82.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $1.71M $373K -$574K -60.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $2.28M $356K -$920K -72.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $3.2M $766K -$370K -32.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $3.57M $211K -$359K -63% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $3.93M $947K +$3K +0.32% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $3.93M $1.28M +$82K +6.87% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $3.84M $1.14M -$78K -6.43% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 $3.92M $570K Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $944K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $1.19M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $1.21M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.